Centene Corporation $CNC Holdings Lowered by Aberdeen Group plc

Aberdeen Group plc lowered its stake in Centene Corporation (NYSE:CNC – Free Report) by 7.3% during the third quarter, HoldingsChannel.com reports. The firm owned 353,105 shares of the company’s stock after selling 27,680 shares during the period. Aberdeen Group plc’s holdings in Centene were worth $21,935,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Frank Rimerman Advisors LLC lifted its holdings in shares of Centene by 3.7% during the 3rd quarter. Frank Rimerman Advisors LLC now owns 4,521 shares of the company’s stock valued at $281,000 after purchasing an additional 163 shares in the last quarter. Journey Retirement Planning & Investment Management LLC increased its stake in Centene by 3.9% during the 3rd quarter. Journey Retirement Planning & Investment Management LLC now owns 4,652 shares of the company’s stock worth $289,000 after purchasing an additional 175 shares in the last quarter. Grove Bank & Trust increased its stake in Centene by 2.0% during the 3rd quarter. Grove Bank & Trust now owns 11,294 shares of the company’s stock worth $702,000 after purchasing an additional 220 shares in the last quarter. GoalVest Advisory LLC increased its stake in Centene by 25.9% during the 3rd quarter. GoalVest Advisory LLC now owns 1,122 shares of the company’s stock worth $70,000 after purchasing an additional 231 shares in the last quarter. Finally, Activest Wealth Management raised its holdings in Centene by 27.4% during the 3rd quarter. Activest Wealth Management now owns 1,163 shares of the company’s stock worth $72,000 after buying an additional 250 shares during the period. 93.63% of the stock is currently owned by institutional investors.

Centene Price Performance

NYSE:CNC opened at $72.52 on Wednesday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.16 and a current ratio of 1.16. The stock’s 50-day simple moving average is $67.38 and its 200 day simple moving average is $56.82. The company has a market cap of $35.90 billion, a P/E ratio of 14.19, a P/E/G ratio of 0.44 and a beta of 1.07. Centene Corporation has a 52-week low of $31.63 and a 52-week high of $78.08.

Centene (NYSE:CNC – Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $0.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.48. Centene had a return on equity of 12.15% and a net margin of 0.72%. The business had revenue of $50.65 billion for the quarter, compared to analyst estimates of $47.12 billion. During the same quarter in the prior year, the company posted $0.50 earnings per share. Centene’s revenue was up 1.9% on a year-over-year basis. As a group, sell-side analysts forecast that Centene Corporation will post 5.27 EPS for the current fiscal year.

Insider Buying and Selling at Centene

In other Centene news, General Counsel Christopher Koster sold 56,500 shares of the business’s stock in a transaction that occurred on Wednesday, August 26th. The stock was sold at an average price of $66.90, for a total transaction of $3,779,850.00. Following the transaction, the general counsel owned 248,854 shares of the company’s stock, valued at $16,648,332.60. The trade was a 18.50% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.37% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Wells Fargo & Company lifted their price target on shares of Centene from $69.00 to $75.00 and gave the company an “equal weight” rating in a research note on Friday, October 30th. Truist Financial restated a “buy” rating and set a $82.00 price objective (up from $80.00) on shares of Centene in a report on Monday, November 2nd. Jefferies Financial Group reaffirmed a “hold” rating and issued a $69.00 price objective on shares of Centene in a research report on Thursday, October 29th. Zacks Research lowered shares of Centene from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 5th. Finally, UBS Group upped their target price on shares of Centene from $70.00 to $78.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 28th. Nine research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $75.10.

Read Our Latest Research Report on CNC

Centene Company Profile

(Free Report)

Centene Corporation is a U.S. health care company that provides managed care and related services, primarily for people enrolled in government-sponsored health programs. Its offerings include Medicaid and Medicare plans, as well as health insurance sold through the Affordable Care Act marketplace. Centene serves members through health plans and a network of health care providers. Its businesses include Ambetter, which offers marketplace health plans, and Wellcare, which provides Medicare-related coverage.

See Also

Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Corporation (NYSE:CNC – Free Report).

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.